Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
A hormonal condition that affects millions of women is difficult for doctors to diagnose and treat. Here’s why
- blkalertshealth
- April 1, 2024
- 0
Why PCOS symptoms are so difficult to diagnose and
Tracking Covid deaths
- blkalertshealth
- March 24, 2024
- 0
NBC News is tracking deaths from Covid-19 in the U
RSV hospitalization rate for seniors is 10 times higher than usual for this point in the season
- blkalertshealth
- March 21, 2024
- 0
The respiratory virus season has started early in